![]() Learn more about radiofrequency ablation » Stanford doctors have conducted clinical studies leading to approval of the radiofrequency energy ablation system measuring contact force to improve ablation outcomes.The Stanford Center for Arrhythmia Research has assembled more than 40 faculty who represent numerous disciplines and are collaborating to solve arrhythmia related problems.A Stanford doctor co-invented a new form of ablation treatment called cryoablation (freezing), which has been used in over 200,000 patients worldwide, including patients with atrial fibrillation and supraventricular tachycardia.Additional Research and Innovation Advancements We work with the Stanford Biodesign Program-an innovative collaboration between medicine and engineering-to develop new technologies in medicine. New diagnostic approaches to patients with inherited arrhythmic disorders.Signal processing and mathematical techniques for diagnosis of arrhythmias.New approaches to ICD and Pacemaker therapy.New treatments for arrhythmias in cardiomyopathies (hypertrophic, ischemic, nonischemic). ![]() Integration of imaging in catheter ablation.New treatments and diagnostic techniques for Atrial Fibrillation.We're actively developing new approaches to arrhythmia diagnosis and treatment, including: Clinical research studies may be sponsored by the National Institutes of Health, other governmental agencies, or industry. The Stanford Cardiac Arrhythmia Service is not only dedicated to treating its patients with the finest treatment options available, but also to advancing those treatments. We prescribe alternative medications that are approved for pregnant and breastfeeding women. Our specialists can perform catheter ablations without using radiation, which minimizes the risk of long-term harm in women who are pregnant or wish to become pregnant. We safely treat pregnant women with arrhythmia while keeping their babies healthy. If women are experiencing any unpleasant side effects from these drugs, our doctors find alternatives so they can live their best quality of life while managing the arrhythmia. Women may also experience a reduced sex drive when on beta blockers, a drug commonly used to treat arrhythmia. Women report more migraines when on certain medications. Some drug treatments for arrhythmia may affect women differently than men. Our cardiologists work with women throughout their lives to give them the expert care they need. Hormone involvement also means that an arrhythmia may be temporary and require short-term care. That means that as women go through changes in their lives, such as pregnancy, breastfeeding, and menopause, their risk for developing an arrhythmia increases. Certain types of arrhythmia, like supraventricular tachycardia (SVT), may be affected by female hormones.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |